This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Bladder Cancer
Conferences
AUA 2014
AUA 2014 - Prostate Cancer
Recent Abstracts
#AUA14 - A more extensive pelvic lymph node dissection is associated with improved survival of patients with node-positive prostate cancer - Session Highlights
May 19, 2014
#AUA14 - Poster: Comparison of toxicity between single and combined modality radiation therapy among low-risk prostate cancer patients
May 19, 2014
#AUA14 - High incidence of predominant Gleason pattern 4 is associated with low testosterone serum level in localized prostate cancer: An update with 937 patients - Session Highlights
May 19, 2014
#AUA14 - Session Highlights: Long term follow-up of a large active surveillance cohort
May 19, 2014
#AUA14 - Multiparametric prostate MRI and MRI/ultrasound fusion biopsy in the follow-up of prostate cancer progression for men on active surveillance - Session Highlights
May 19, 2014
#AUA14 - Magnetic resonance imaging/ultrasound-fusion biopsy better predicts whole gland pathology on radical prostatectomy compared to standard 12-core biopsy - Session Highlights
May 19, 2014
#AUA14 - Rectal culture prior to prostate biopsy identifies men at risk for infection: A multi-institutional international collaborative study - Session Highlights
May 19, 2014
#AUA14 - Multiparametric MRI characteristics of patients upgraded by MRI/ultrasound fusion guided biopsy across PSA-based cutoffs - Session Highlights
May 18, 2014
#AUA14 - Long term follow up of a large active surveillance cohort - Session Highlights
May 18, 2014
#AUA14 - Long-term incidence of hematuria, urethral stricture, and bladder cancer following radiation therapy for prostate cancer - Session Highlights
May 18, 2014
#AUA14 - SPOP mutations in prostate cancer - Session Highlights
May 18, 2014
#AUA14 - Signaling pathways and implications for cancer immunotherapy - Session Highlights
May 18, 2014
#AUA14 - Transitioning from drug to therapy development of prostate cancer - Session Highlights
May 18, 2014
#AUA14 - Comparison of three multi-parametric MRI scoring systems for the detection of prostate cancer on MR/TRUS fusion guided prostate biopsy - Session Highlights
May 18, 2014
#AUA14 - Prostate cancer partner perspective -- unmet needs - Session Highlights
May 18, 2014
#AUA14 - The number of systematic biopsy cores raises predominantly the detection of insignificant cancer - Session Highlights
May 18, 2014
#AUA14 - Visualization of periprostatic nerve fibers before and after radical prostatectomy using diffusion tensor magnetic resonance imaging with tractography - Session Highlights
May 17, 2014
#AUA14 - Neoadjuvant approaches for high-risk prostate cancer - Session Highlights
May 17, 2014
#AUA14 - Crossfire: Controversies in Urology - Should the urologist treat hormone resistant prostate cancer? - Session Highlights
May 16, 2014
Page 3 of 3
Start
Prev
1
2
3
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free